MedKoo Cat#: 578136 | Name: Nicametate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Nicametate is a cardiovascular agent and vasodilator.

Chemical Structure

Nicametate
Nicametate
CAS#3099-52-3

Theoretical Analysis

MedKoo Cat#: 578136

Name: Nicametate

CAS#: 3099-52-3

Chemical Formula: C12H18N2O2

Exact Mass: 222.1368

Molecular Weight: 222.29

Elemental Analysis: C, 64.84; H, 8.16; N, 12.60; O, 14.39

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Nicametate
IUPAC/Chemical Name
2-(Diethylamino)ethyl nicotinate
InChi Key
JVWOCHRRAWHKLT-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H18N2O2/c1-3-14(4-2)8-9-16-12(15)11-6-5-7-13-10-11/h5-7,10H,3-4,8-9H2,1-2H3
SMILES Code
CCN(CC)CCOC(=O)c1cccnc1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 222.29 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Wang TA, Wu TH, Pan SL, Chen HH, Chiu SY. Impacts of treatments on recurrence and 28-year survival of ischemic stroke patients. Sci Rep. 2021 Jul 27;11(1):15258. doi: 10.1038/s41598-021-94757-6. PMID: 34315990; PMCID: PMC8316573. 2. Lee TK, Chan KW, Huang ZS, Ng SK, Lin RT, Po HL, Yuan RY, Lai ML, Chang TW, Yan SH, Deng JC, Liu LH, Lee KY, Lie SK, Sung SM, Hu HH. Effectiveness of low-dose ASA in prevention of secondary ischemic stroke, the ASA Study Group in Taiwan. Thromb Res. 1997 Jul 15;87(2):215-24. doi: 10.1016/s0049-3848(97)00121-7. PMID: 9259112.